๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection

โœ Scribed by Meiqiang Liu; Bangwei Cao; Hongkun Zhang; Yue Dai; Xiaolin Liu; Changqing Xu

Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
130 KB
Volume
58
Category
Article
ISSN
0093-7711

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Association of the โˆ’183 polymorphism in
Association of the โˆ’183 polymorphism in the IFN-ฮณ gene promoter with hepatitis B virus infection in the Chinese population
โœ Suxia Qi; Bangwei Cao; Mingwei Jiang; Changqing Xu; Yue Dai; Kun Li; Kun Wang; Y ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 153 KB ๐Ÿ‘ 1 views

Interferon-c (IFN-c) is a pleiotropic cytokine that plays an important role in regulating cellular immune responses. Regulation of IFN-c expression is considered to be strictly controlled at the transcriptional level. Two single-nucleotide polymorphisms (SNPs) within the human IFN-c promoter (at pos

Association of candidate susceptible loc
Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population
โœ Ding-Qiang Chen; Yong Zeng; Jie Zhou; Ling Yang; Shibo Jiang; Jian-Dong Huang; L ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 1 views

## Abstract A number of genetic loci have been proposed to be associated with persistent hepatitis B virus (HBV) infection. This study aimed to evaluate the association and interaction of susceptible genes with HBV persistence in a Chinese population. A total of 17 polymorphisms in 9 candidate gene

A randomised controlled trial of recombi
A randomised controlled trial of recombinant interferon-ฮณ in chinese patients with chronic hepatitis B virus infection
โœ Johnson Y. N. Lau; Dr. C. L. Lai; P. C. Wu; H. T. Chung; Anna S. F. Lok; H. J. L ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 433 KB

## Abstract Nineteen Chinese patients with chronic hepatitis B virus (HBV) infection, seropositive for HBV e antigen (HBeAg) and HBV DNA on at least three occasions in 6 months, were randomised to receive either recombinant human interferongamma (rlFNฮณ) 0.1 mg/m^2^ intramuscularly thrice weekly for